Sign Up to like & get recommendations! 1
Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-022-05108-y
Abstract: Physiologically based pharmacokinetic (PBPK) modeling can be a useful tool for characterizing nicotine pharmacokinetics (PK) from use of tobacco products. We expand a previously published PBPK model to simulate a nicotine PK profile, following single… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Drug research"
DOI: 10.1055/a-1852-5391
Abstract: Vancomycin is a commonly used antibiotic for multi-drug resistant gram-positive infections treatment, especially methicillin-resistant Staphylococcus aureus (MRSA). Despite that, it has wide individual pharmacokinetic variability and nephrotoxic effect. Vancomycin trough concentrations for 57 Jordanian patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14609
Abstract: This study aims to develop and verify a physiologically based pharmacokinetic (PBPK) population model for the Chinese geriatric population in Simcyp. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Dissolution Technologies"
DOI: 10.14227/dt260319p18
Abstract: Recently the pharmaceutical sector has witnessed a drastic rise in the advancement and incorporation of computerbased technology into several unit operations. Drug dissolution profiling is an important consideration for the successful development of immediate and… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Current drug metabolism"
DOI: 10.2174/1389200223666220628095616
Abstract: BACKGROUND Andrographolide has a potent antiviral effect for the treatment of coronavirus disease (COVID-19). However, there are no in vivo studies of andrographolide as an anti-COVID-19 treatment. OBJECTIVE The study aims to develop a physiologically… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1029073
Abstract: The cytochrome P450 2D6 (CYP2D6) is a key xenobiotic-metabolizing enzyme involved in the clearance of many drugs. Genetic polymorphisms in CYP2D6 contribute to the large inter-individual variability in drug metabolism and could affect metabolic phenotyping… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Nanomaterials"
DOI: 10.3390/nano10071267
Abstract: There have been efforts to develop physiologically based pharmacokinetic (PBPK) models for nanomaterials (NMs). Since NMs have quite different kinetic behaviors, the applicability of the approaches and techniques that are utilized in current PBPK models… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13091402
Abstract: One of the main obstacles in neurological disease treatment is the presence of the blood–brain barrier. New predictive high-throughput screening tools are essential to avoid costly failures in the advanced phases of development and to… read more here.